SynCore BiotechnologyLtd Balance Sheet Health
Financial Health criteria checks 6/6
SynCore BiotechnologyLtd has a total shareholder equity of NT$357.1M and total debt of NT$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are NT$378.4M and NT$21.2M respectively.
Key information
0%
Debt to equity ratio
NT$0
Debt
| Interest coverage ratio | n/a |
| Cash | NT$271.36m |
| Equity | NT$357.14m |
| Total liabilities | NT$21.23m |
| Total assets | NT$378.36m |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: 4192's short term assets (NT$310.5M) exceed its short term liabilities (NT$21.2M).
Long Term Liabilities: 4192 has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: 4192 is debt free.
Reducing Debt: 4192 had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 4192 has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: 4192 has sufficient cash runway for 2.2 years if free cash flow continues to grow at historical rates of 9.9% each year.